Taken together, these results suggest that plasma NGAL concentrations are strongly associated with an increased risk of new-onset CKD, which is mainly driven by new-onset CKD as defined by renal function decline, and strongly dependent on baseline renal function. The gene discussed is LCN2; the disease is chronic kidney disease.